| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |